COMP <GO>
ZYME vs SEPN // ENTERPRISE SCALE & MARKET CAP
Zymeworks Inc. (NASDAQ) VS. Septerna Inc. (NASDAQ) • 15-METRIC TALLY: ZYME 1
— SEPN 6
▲ ENTERPRISE SCALE & MARKET CAP LEADER: SEPN
LAST: $28.99 (+1.33%) • MKT CAP: $2.02B
market-cap
$2.02B
LAST: $43.20 (-1.82%) • MKT CAP: $2.05B
market-cap
$2.05B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ZYME VS. SEPN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ZYME | SEPN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -32.20% | -20.70% | -11.50 | SEPN | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -1.71% | 5.19% | -6.90 | SEPN | /fcf-yield <GO> |
| Operating Margin | -60.00% | -60.00% | 0.00 | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -60.00% | 0.00 | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 38.90% | 180.00% | -141.10 | SEPN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 11.85 | 5.87 | +5.98 | ZYME | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 6/9 | -2.00 | SEPN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 60.0 | 62.4 | -2.40 | SEPN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $2.02B | $2.05B | -$37.5M | SEPN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ZYME REV | SEPN REV | ZYME GROSS % | SEPN GROSS % | ZYME FCF | SEPN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $106.0M | $46.0M | — | — | -$34.5M | $109.7M |
| FY 2024 | $76.3M | $1.1M | — | — | -$112.0M | -$69.6M |
| FY 2023 | $76.0M | $151.0K | — | — | -$118.3M | -$38.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ZYME // BETA —
SEPN // BETA —